Title:Exploration of the Synergistic Effects of Phytoconstituents of Ashwagandha, Amla, and Ginger as a Potent Immunity-boosting Agent for COVID-19 Affected Individuals
Volume: 3
Issue: 1
Author(s): Raktimava Das Sarkar, Aryama Bose and Anandamoy Rudra*
Affiliation:
- Department of Pharmaceutics, Bengal School of Technology, Sugandha, Chinsurah, Hooghly, WB, 712102, India
Keywords:
Nutraceuticals, COVID-19, SARS-CoV-2, amla, ashwagandha, ginger, immunity booster.
Abstract: The ongoing threat of COVID-19 has prompted us to search for innovative strategies
to enhance immune responses in affected patients. Phytoconstituents derived from Ashwagandha,
Amla, and Ginger have gained attention due to their historical usage in traditional medicine
and potential immune-modulatory, antioxidant, and antiviral properties. This review investigates
the synergistic effects of phytoconstituents from Ashwagandha, Amla, and Ginger to identify
potential immunity-boosting agents for COVID-19 patients. The investigation involved a comprehensive
analysis of the immune-modulatory compounds present in Ashwagandha, the high
vitamin C content in Amla, and the immunomodulatory constituents in Ginger. The concept of
"phytochemical synergy" was explored, hypothesizing that their combined effects could enhance
antiviral capabilities. The combined phytoconstituents from Ashwagandha, Amla, and Ginger
demonstrated a potential synergistic interaction, suggesting an amplified immune-boosting effect.
The adaptogenic properties of Ashwagandha, the rich vitamin C source in Amla, and the
immunomodulatory components of Ginger appeared to complement each other, contributing to
a holistic approach to viral resistance. While the investigation into the synergy of Ashwagandha,
Amla, and Ginger holds promise as an immunity-boosting strategy, careful consideration is warranted
due to factors like appropriate dosing, safety profiles, and potential interactions with conventional
treatments. This study underscores the significance of combining traditional wisdom
with modern research efforts. As the world continues to combat the complexities of COVID-19,
exploring these botanical sources serves as a reminder of the abundant resources nature offers.
While further rigorous research and clinical trials are essential, pursuing these phytoconstituents
exemplifies our commitment to exploring all viable avenues in the battle against COVID-19.
